Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Colavita365 who wrote (11495)	12/19/2018 1:30:05 PM
From: BoredMember	Read Replies (1) \| Respond to of 12873

The NNVC technology is certainly the best thing since sliced bread and needs to be brought to fruition. NOBODY on the street is saying they love the technology. They certainly may be saying they hate the management, but to be 100% clear - the technology does not work. It never has and never will. Ask Dr. Eva Harris. It has never been verifiably confirmed to work by anyone outside of NNVC's payroll. There is a reason for that. Also, regardless of what Straynut writes, or the word count of his posts, Nanoviricides does not have rights to Shingles treatment. Nor has Nanoviricides produced kg scale batches. All this is irrelevant as the science doesn't work. That is why they've gotten away with this for so long. The assumption that there is any real technology at work has everyone focussing on the next steps when in actuality, there was never a successful first step.